Updates to "The Trial"

With apologies for the email bandwidth impact.

I have located the text in the Clinical Overview (p. 79) that accounts for the majority of “withdrawn” participants: They were expired and wrongly diluted doses! Somehow, this escaped my first Cmd-F sweep.

The original post has been updated, along with a correction notice, and a relevant footnote regarding mis-dosing in children and adults (meanwhile, there are still enough unaccounted-for withdrawals to have left the original text in tact).

Additionally, I have added a double-disclaimer to the original disclaimer that much of what is in the Clinical Overview is probably already available knowledge: In fact, the raw numbers and plot of cases after the 1st dose were already published in the NEJM trial results last year!

Although I have spent hours trawling the Pfizer trial protocol (available in the appendix to the NEJM paper), I still haven’t bothered to read the paper itself - under the assumption that nothing interesting would have made it into what is essentially a giant advertisement. Only by coincidence of encountering the Canadian Covid Care Alliance’s “More Harm than Good” pamphlet (pdf at skirsch.com, see also Kirsch’s post at his substack; hat-tip to reader Guido Vobig for pointing out the pamphlet) did I happen to learn that the paper included the same chart “released” in the FDA’s recent document dump.

So, I could have offered this hot take on the “worry window” months and months ago. Who knew. (Meanwhile, I still encourage reading the first 30 pages of the report itself for all the points I did not highlight, many of which may in fact be new revelations: https://phmpt.org/wp-content/uploads/2021/12/STN-125742_0_0-Section-2.5-Clinical-Overview.pdf, from https://phmpt.org/pfizers-documents/.)

Thanks for subscribing to Unglossed!